Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Saved in:
| Title: | Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. |
|---|---|
| Authors: | Veljovich DS; Swedish Cancer Institute, Seattle, WA., Rothe M; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Ali-Ahmad HM; Michigan Cancer Research Consortium, Lansing, MI., Naumann RW; Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC., Siedel J; University of Michigan, Ann Arbor, MI., Chan JK; Sutter Cancer Research Consortium, San Francisco, CA., Gregory A; Advocate Aurora Healthcare, Milwaukee, WI., Pisick E; City of Hope Chicago, Zion, IL., Adesunloye B; City of Hope Atlanta, Atlanta, GA., Arend RC; Division of Gynecologic Oncology, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham, AL., Bell M; Sanford Health, Sioux Falls, SD., Frimer M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Northwell Health, Northwell Health Cancer Institute, New Hyde Park, NY., Tawfik B; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM., Thota R; Intermountain Healthcare, Murray, UT., Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, TX., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Hinshaw DC; American Society of Clinical Oncology, Alexandria, VA., Gregory A; American Society of Clinical Oncology, Alexandria, VA., Grantham GN; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2026 Jul; Vol. 10 (7), pp. e2600456. Date of Electronic Publication: 2026 Jul 15. |
| Publication Type: | Journal Article; Clinical Trial, Phase II |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
